Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Rani Therapeutics LLC is currently managing 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 5 distinct examiners, indicating that pending cases are being reviewed by different individuals. This distribution is further evidenced by the busiest examiner, Benjamin K Koo.
The 5 pending office actions are situated within 3 distinct art units. This suggests that while the company's innovations are focused on biotechnology and pharmaceuticals, they fall into 3 specialized examination groups. The ratio of distinct examiners to art units shows that even within the same group, the company is likely interacting with multiple different officials.
For practitioners, the presence of 5 distinct examiners across the 3 distinct art units requires a diversified prosecution approach. Because the busiest examiner pending count is only 1, the portfolio's progress is not overly dependent on any individual examiner's tendencies. Each action represents an independent opportunity to secure patent rights, requiring tailored responses to the specific prior art and legal arguments raised by each official.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| Double-patenting + other | 2 (40%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOO, BENJAMIN K | 1 | 57.1% | +49.7% |
| CARTER, SANDRA DILLAHUNT | 1 | 56.2% | +29.0% |
| D' AMBROSIO, THEA | 1 | 55.3% | +56.1% |
| IGEL JR, MARK ALAN | 1 | 66.5% | +28.7% |
| WITTLIFF, KATERINA ANNA | 1 | 35.0% | +18.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18810258 | DEVICES, ASSEMBLIES, AND METHODS FOR DELIVERING A FLUID PREPARATION INTO A GASTROINTESTINAL TRACT | KOO, BENJAMIN K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17709245 | SELF-SIZING DEVICE FOR DELIVERING A FORMULATION TO A LUMEN WALL | WITTLIFF, KATERINA ANNA | 32d overdue |
| 18810258 | DEVICES, ASSEMBLIES, AND METHODS FOR DELIVERING A FLUID PREPARATION INTO A GASTROINTESTINAL TRACT | KOO, BENJAMIN K | — |
| 18481893 | THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE | CARTER, SANDRA DILLAHUNT | — |
| 18452358 | TREATMENTS FOR HEMOPHILIA A | D' AMBROSIO, THEA | — |
| 17863806 | SWALLOWABLE DEVICES FOR DRUG DELIVERY IN AN INTESTINAL TRACT | IGEL JR, MARK ALAN | — |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1674 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18810258 | DEVICES, ASSEMBLIES, AND METHODS FOR DELIVERING A FLUID PREPARATION INTO A GASTROINTESTINAL TRACT | KOO, BENJAMIN K | — | §102§103§112 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18481893 | THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE | CARTER, SANDRA DILLAHUNT | 1674 | DPOther | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18452358 | TREATMENTS FOR HEMOPHILIA A | D' AMBROSIO, THEA | 1654 | §103§112DP | Non-Final OA | — | Pending | Aug 18, 2023 |
| 17863806 | SWALLOWABLE DEVICES FOR DRUG DELIVERY IN AN INTESTINAL TRACT | IGEL JR, MARK ALAN | 3783 | §103 | Final Rejection | — | Pending | Jul 13, 2022 |
| 17709245 | SELF-SIZING DEVICE FOR DELIVERING A FORMULATION TO A LUMEN WALL | WITTLIFF, KATERINA ANNA | 3783 | §103 | Non-Final OA | 32d overdue | Pending | Mar 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial